Member of the Association of American Physicians
Antibiotic resistance, Antibiotics, Microbiology, Drug resistance and Acinetobacter baumannii are his primary areas of study. His Antibiotic resistance research integrates issues from Natural selection, Genetic Fitness and Cephalosporin. His Antibiotics research includes elements of Antimicrobial, Computational biology, Fitness landscape, Avibactam and Pharmacology.
His studies in Microbiology integrate themes in fields like Serratia marcescens, Virology and Bacteria. The study incorporates disciplines such as Vaborbactam, Ampicillin, Ticarcillin and Sulbactam in addition to Drug resistance. His research investigates the connection with Acinetobacter baumannii and areas like Bacteremia which intersect with concerns in Intensive care medicine, Clinical trial, Observational study and Sepsis.
His primary areas of study are Microbiology, Antibiotic resistance, Klebsiella pneumoniae, Antibiotics and Acinetobacter baumannii. His Microbiology study incorporates themes from Gene, Enterobacteriaceae and Escherichia coli. His biological study spans a wide range of topics, including Efflux, Computational biology and Drug resistance.
In his research, Horizontal gene transfer is intimately related to Plasmid, which falls under the overarching field of Klebsiella pneumoniae. His work deals with themes such as Ceftazidime, Ceftazidime/avibactam and Avibactam, which intersect with Antibiotics. Robert A. Bonomo has included themes like Ampicillin, Ticarcillin, Sulbactam and Beta-Lactamase Inhibitors in his Pharmacology study.
Robert A. Bonomo mostly deals with Microbiology, Klebsiella pneumoniae, Antibiotic resistance, Internal medicine and Acinetobacter baumannii. His Microbiology research is multidisciplinary, incorporating perspectives in Gene, Enterobacteriaceae and Carbapenem resistant. The Antibiotic resistance study which covers β lactamases that intersects with Signal transduction.
His Internal medicine research includes themes of Multilocus sequence typing and Drug resistance. His research in Drug resistance intersects with topics in Ceftolozane, Tazobactam, Aminoglycoside, Pharmacology and Polymyxin. His biological study focuses on Cephalosporin.
Microbiology, Antibiotic resistance, Klebsiella pneumoniae, Carbapenem resistant and Genetics are his primary areas of study. His Microbiology study integrates concerns from other disciplines, such as Carbapenem-resistant enterobacteriaceae and Gene, Virulence. His Antibiotic resistance research is classified as research in Antibiotics.
His research integrates issues of Internal medicine, Prospective cohort study, In silico and Acinetobacter baumannii in his study of Klebsiella pneumoniae. His study on Genotype, Susceptibility testing, Phenotype and Agar dilution is often connected to Breakpoint as part of broader study in Genetics. His work focuses on many connections between Gram-negative bacteria and other disciplines, such as Siderophore, that overlap with his field of interest in Cephalosporin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Extended-spectrum beta-lactamases: a clinical update.
David L. Paterson;Robert A. Bonomo.
Clinical Microbiology Reviews (2005)
Three Decades of β-Lactamase Inhibitors
Sarah M. Drawz;Robert A. Bonomo;Robert A. Bonomo.
Clinical Microbiology Reviews (2010)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L Silvia Munoz-Price;L Silvia Munoz-Price;Laurent Poirel;Robert A Bonomo;Robert A Bonomo;Mitchell J Schwaber.
Lancet Infectious Diseases (2013)
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.
Darren Wong;Travis B. Nielsen;Robert A. Bonomo;Paul Pantapalangkoor.
Clinical Microbiology Reviews (2016)
Analysis of Antibiotic Resistance Genes in Multidrug-Resistant Acinetobacter sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center
Kristine M. Hujer;Andrea M. Hujer;Edward A. Hulten;Saralee Bajaksouzian.
Antimicrobial Agents and Chemotherapy (2006)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belén Gutiérrez-Gutiérrez;Elena Salamanca;Marina de Cueto;Po-Ren Hsueh.
Lancet Infectious Diseases (2017)
Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding
Liang Chen;Barun Mathema;Kalyan D. Chavda;Frank R. DeLeo.
Trends in Microbiology (2014)
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David Van Duin;Judith J. Lok;Michelle Earley;Eric Cober.
Clinical Infectious Diseases (2018)
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
Andrea Endimiani;Andrea M. Hujer;Federico Perez;Christopher R. Bethel.
Journal of Antimicrobial Chemotherapy (2009)
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations.
David van Duin;Robert A. Bonomo.
Clinical Infectious Diseases (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: